Excelsior Biopharma Inc. (6496.TWO)

27.95 -0.10 (-0.36%) At close: 12:48PM CST

Excelsior Biopharma Inc.

No.3, Park Street
14th Floor - 6 Nangang District
Taipei 11503
Taiwan
886 2 2655 7568
https://www.excelsiorgroup.com.tw

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Joseph Chen	Founder, Chairman, President & GM	N/A	N/A	N/A
Mr. MingTse Chen	Financial Manager & Chief Accountant	N/A	N/A	N/A
Ms. HuiChen Liu	Representative Director & Administration Department Manager	N/A	N/A	N/A
Mr. Po-Tang Cheng	Senior Sales Director	N/A	N/A	N/A
Ms. Chialing Chen	Representative Director, New Business Development Manager & Associate Manger to the President Office	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.

Description

Excelsior Biopharma Inc. develops and sells pharmaceutical products in Taiwan, China, and internationally. It offers prescription drugs, over-the-counter drugs, medical devices, healthcare food products, medical supplies, and other products. The company provides its products for the therapeutic areas, such as pediatrics, gastroenterology, neurology, cardiology, dermatology, medical toxicology, dentistry, obstetrics, oncology, hematology, and otorhinolaryngology, as well as infectious diseases. It also offers test kits under the Actim name to detect influenza virus, fecal occult blood, acute pancreatitis, preterm or full-week delivery, and early water breaking. In addition, the company provides toothpaste, and mouth wash and gel products under the Oral7 name; and food and medical beauty maintenance products. Further, it imports and exports active pharmaceutical ingredients; and engages in the research of technologies, and pharmaceutical technologies transfer and cooperative development and improvement activities. The company was formerly known as Excelsior Enterprise Co., Ltd. and changed its name to Excelsior Biopharma Inc. in June 2003. Excelsior Biopharma Inc. was incorporated in 1988 and is headquartered in Taipei, Taiwan.

Corporate governance

Excelsior Biopharma Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.